Clinical and prognostic features of Langerhans cell histiocytosis in adults.
BRAF mutation
Langerhans cell histiocytosis
adult
nationwide survey
prognosis
Journal
Cancer science
ISSN: 1349-7006
Titre abrégé: Cancer Sci
Pays: England
ID NLM: 101168776
Informations de publication
Date de publication:
Sep 2023
Sep 2023
Historique:
revised:
18
04
2023
received:
11
09
2022
accepted:
21
05
2023
medline:
5
9
2023
pubmed:
27
6
2023
entrez:
26
6
2023
Statut:
ppublish
Résumé
Langerhans cell histiocytosis (LCH) is a rare disease characterized by clonal expansion of CD1a
Identifiants
pubmed: 37364599
doi: 10.1111/cas.15879
pmc: PMC10475785
doi:
Substances chimiques
Proto-Oncogene Proteins B-raf
EC 2.7.11.1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3687-3697Subventions
Organisme : the Japanese National Research Group on Idiopathic Bone Marrow Failure Syndromes
ID : 20FC1018
Informations de copyright
© 2023 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.
Références
Lancet Oncol. 2005 Jun;6(6):435-7
pubmed: 15925822
Trends Mol Med. 2020 May;26(5):519-528
pubmed: 32359482
Int J Hematol. 2020 Aug;112(2):185-192
pubmed: 32514929
N Engl J Med. 2002 Feb 14;346(7):484-90
pubmed: 11844849
Cancer Med. 2019 Jan;8(1):58-66
pubmed: 30597769
Am J Surg Pathol. 2018 Feb;42(2):150-159
pubmed: 29194093
Med Pediatr Oncol. 1997 Jan;28(1):9-14
pubmed: 8950330
Bone Marrow Transplant. 2013 Mar;48(3):452-8
pubmed: 23208313
Br J Haematol. 2016 Sep;174(6):887-98
pubmed: 27273725
Mol Cancer Ther. 2021 Jul;20(7):1316-1323
pubmed: 33879554
Science. 2017 Mar 24;355(6331):1330-1334
pubmed: 28336671
Blood. 2013 Jun 20;121(25):5006-14
pubmed: 23589673
Ann Oncol. 2010 Jun;21(6):1173-1178
pubmed: 19861578
PLoS One. 2012;7(8):e43257
pubmed: 22916233
Front Med (Lausanne). 2021 Mar 08;7:582581
pubmed: 33763431
Blood. 2010 Sep 16;116(11):1919-23
pubmed: 20519626
Orphanet J Rare Dis. 2013 May 14;8:72
pubmed: 23672541
Cancer. 2006 Aug 1;107(3):613-9
pubmed: 16804933
Int J Hematol. 2013 Jan;97(1):103-8
pubmed: 23243004
Blood. 1999 Jun 15;93(12):4125-30
pubmed: 10361109
J Clin Oncol. 2016 Sep 1;34(25):3023-30
pubmed: 27382093
Pediatr Blood Cancer. 2010 Mar;54(3):416-23
pubmed: 19908293
Leuk Res. 2016 Mar;42:43-6
pubmed: 26859782
Blood. 2008 Mar 1;111(5):2556-62
pubmed: 18089850
Pediatr Blood Cancer. 2006 Feb;46(2):228-33
pubmed: 16047354
J Pediatr. 2001 May;138(5):728-34
pubmed: 11343051
Cancer Sci. 2023 Sep;114(9):3687-3697
pubmed: 37364599
Int J Hematol. 2016 Jul;104(1):99-109
pubmed: 27040279
Hematol Oncol Clin North Am. 2015 Oct;29(5):825-38
pubmed: 26461145
Eur J Cancer. 2003 Nov;39(16):2341-8
pubmed: 14556926
J Clin Invest. 2020 Dec 1;130(12):6668-6676
pubmed: 32897884
Cancer Sci. 2018 Dec;109(12):3707-3713
pubmed: 30281871
Br J Haematol. 2018 Nov;183(4):608-617
pubmed: 30421536
Blood. 2016 Jun 2;127(22):2672-81
pubmed: 26966089
Pediatr Blood Cancer. 2013 Feb;60(2):175-84
pubmed: 23109216
Med Pediatr Oncol. 2002 Dec;39(6):581-5
pubmed: 12376981
Blood Adv. 2023 Feb 28;7(4):664-679
pubmed: 36083130